HDAC Inhibitors in Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2019 at "Cancers"
DOI: 10.3390/cancers11111794
Abstract: Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled proliferation, differentiation arrest, and accumulation of immature myeloid progenitors. Although clinical advances in AML have been made, especially in young patients, long-term disease-free survival… read more here.
Keywords: use; myeloid leukemia; hdac inhibitors; inhibitors acute ... See more keywords
The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12122062
Abstract: (1) Background: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors constitute a novel drug class with remarkable cardiovascular benefits for patients with chronic heart failure (HF). Recently, this class has been utilized in acute HF as an additional treatment… read more here.
Keywords: pathophysiologic mechanisms; heart failure; sglt inhibitors; relevant studies ... See more keywords